SK Biopharmaceuticals said on the 16th that it will participate in Bio USA. It is a global event where more than 20,000 pharmaceutical and biotech officials and biotechnology researchers gather to discuss technology transfer and investment. It will be held in San Diego from the 22nd to the 25th (local time).
SK Biopharmaceuticals has operated a solo booth for two consecutive years since last year. This year, it will present ways to use artificial intelligence (AI) for research and development of new drugs and to support patients. The plan is to use AI across operations to boost productivity.
In addition, it plans to hold meetings with overseas corporations to discuss potential cooperation. It said it will present its new drug development capabilities to investors and seek business opportunities.
Lee Dong-hoon, president of SK Biopharmaceuticals, said, "It is an opportunity to seek partnership opportunities with the pharmaceutical and biotech industry," adding, "We will improve the productivity of new drug development with AI and provide the treatments patients need."